Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Bullboard Posts
Post by extreme22on Jul 23, 2009 9:32am
324 Views
Post# 16159638

Financing closed and accepted by TSX

Financing closed and accepted by TSX$0$0iCo Therapeutics 1,187,500-share private placement$0$0$0$0$02009-07-22 19:23 ET - Private Placement$0$0The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement announced July 16, 2009:$0$0$0$0Number of shares:  1,187,500 shares$0$0Purchase price:  40 cents per share$0$0Hidden placees:  17 hidden placees participated$0$0Pro groups:  Scott Hunter, 100,000; Christian ter Keurs, 200,000$0$0Insiders:  Andrew Rae, 30,000; John Clement, 6,250$0$0Finders' fees:  7 per cent in cash based on the proceeds raised by each payable to Haywood Securities ($2,800), Pathfinder Ventures Corp. (Greg Andrews) ($3,500), Pure Advertising & Marketing (Kam Thindal) ($8,400), Loewen, Ondaatje, McCutcheon ($3,500), and B&D Capital (Don Mosher) ($2,100)$0
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse